OncoVee™-mini-patient-derived xenograft guided adjuvant chemotherapy treatment for resectable gastric cancer

doi:10.4251/wjgo.v18.i7.118050

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 7

This Article

(19)

(0)

(276)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Jul 15, 2026; 18(7): 118050
Published online Jul 15, 2026. doi: 10.4251/wjgo.v18.i7.118050

Table 1 Comparison of patient-derived xenograft and mini patient-derived xenograft for gastric cancer

	PDX	MiniPDX
Model establishment time (median days)¹	70-112	7
Modeling success rate	15.1%-35.5%	100%
Reference	[39-43]	[24]

¹The time required for modeling patient-derived xenograft, defined as the duration from the implantation of human-derived tumor tissue into the first generation of tumor-bearing mice (trans generation 1) until the passage to the second generation of tumor-bearing mice (trans generation 2), was measured in days.

PDX: Patient-derived xenograft; MiniPDX: Mini patient-derived xenograft.

Full Size Table

Citation: Qiu YX, Jian KY, Xu QR, Lu X, Jia BL, Jiang L, Liang F. OncoVee™-mini-patient-derived xenograft guided adjuvant chemotherapy treatment for resectable gastric cancer. World J Gastrointest Oncol 2026; 18(7): 118050
URL: https://www.wjgnet.com/1948-5204/full/v18/i7/118050.htm
DOI: https://dx.doi.org/10.4251/wjgo.v18.i7.118050

Qiu YX, Jian KY, Xu QR, Lu X, Jia BL, Jiang L, Liang F. OncoVee™-mini-patient-derived xenograft guided adjuvant chemotherapy treatment for resectable gastric cancer. World J Gastrointest Oncol 2026; 18(7): 118050 [DOI: 10.4251/wjgo.v18.i7.118050]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.